Search Results - "Crouch, Eric R"

Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity by Wallace, David K, Kraker, Raymond T, Freedman, Sharon F, Crouch, Eric R, Bhatt, Amit R, Hartnett, M Elizabeth, Yang, Michael B, Rogers, David L, Hutchinson, Amy K, VanderVeen, Deborah K, Haider, Kathryn M, Siatkowski, R Michael, Dean, Trevano W, Beck, Roy W, Repka, Michael X, Smith, Lois E, Good, William V, Kong, Lingkun, Cotter, Susan A, Holmes, Jonathan M

“…Intravitreous bevacizumab (0.25 mg to 0.625 mg) is commonly used to treat type 1 retinopathy of prematurity (ROP), but there are concerns about systemic…”
Get more information

Optical Treatment of Strabismic and Combined Strabismic–Anisometropic Amblyopia by Cotter, Susan A., OD, MS, Foster, Nicole C., MS, Holmes, Jonathan M., BM, BCh, Melia, B. Michele, ScM, Wallace, David K., MD, MPH, Repka, Michael X., MD, Tamkins, Susanna M., OD, Kraker, Raymond T., MSPH, Beck, Roy W., MD, PhD, Hoover, Darren L., MD, Crouch, Eric R., MD, Miller, Aaron M., MD, Morse, Christie L., MD, Suh, Donny W., MD

“…Objective To determine visual acuity improvement in children with strabismic and combined strabismic–anisometropic (combined-mechanism) amblyopia treated with…”
Get full text

Effect of a Binocular iPad Game vs Part-time Patching in Children Aged 5 to 12 Years With Amblyopia: A Randomized Clinical Trial by Holmes, Jonathan M, Manh, Vivian M, Lazar, Elizabeth L, Beck, Roy W, Birch, Eileen E, Kraker, Raymond T, Crouch, Eric R, Erzurum, S Ayse, Khuddus, Nausheen, Summers, Allison I, Wallace, David K

“…A binocular approach to treating anisometropic and strabismic amblyopia has recently been advocated. Initial studies have yielded promising results, suggesting…”
Get more information

Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing Study by Wallace, David K, Kraker, Raymond T, Freedman, Sharon F, Crouch, Eric R, Hutchinson, Amy K, Bhatt, Amit R, Rogers, David L, Yang, Michael B, Haider, Kathryn M, VanderVeen, Deborah K, Siatkowski, R Michael, Dean, Trevano W, Beck, Roy W, Repka, Michael X, Smith, Lois E, Good, William V, Hartnett, Mary Elizabeth, Kong, Lingkun, Holmes, Jonathan M

“…Intravitreous bevacizumab (0.25 to 0.625 mg) is increasingly used to treat type 1 retinopathy of prematurity (ROP), but there remain concerns about systemic…”
Get more information

Doses of medial rectus muscle recessions for divergence insufficiency-type esotropia by Miller, Aaron M., Holmes, Jonathan M., Wu, Rui, Kraker, Raymond T., Crouch, Eric R., Lee, Katherine A., Del Monte, Monte A., Marsh, Justin D., Kraus, Courtney L., Wallace, David K., Colburn, Jeffrey D., Kemp, Pavlina S., Cotter, Susan A.

“…We evaluated whether doses of bilateral medial rectus recessions greater than Parks’s tables yielded superior outcomes for adult-onset divergence…”
Get full text

Rasch-calibrated Intermittent Exotropia Symptom Questionnaire for Children by Holmes, Jonathan M., Leske, David A., Hercinovic, Amra, Hatt, Sarah R., Chandler, Danielle L., Li, Zhuokai, Melia, B. Michele, Chen, Angela M., Erzurum, Sergul Ayse, Crouch, Eric R., Jenewein, Erin C., Kraker, Raymond T., Cotter, Susan A.

“…A rigorously designed and calibrated symptom questionnaire for childhood intermittent exotropia would be useful for clinical care and for research. The aim of…”
Get full text

Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity by Wallace, David K., Hercinovic, Amra, Freedman, Sharon F., Crouch, Eric R., Bhatt, Amit R., Hartnett, M. Elizabeth, Yang, Michael B., Rogers, David L., Hutchinson, Amy K., Good, William V., Repka, Michael X., Li, Zhuokai, Beck, Roy W., Kraker, Raymond T., Cotter, Susan A., Holmes, Jonathan M.

“…To report 2-year ocular and developmental outcomes for infants receiving low doses of intravitreal bevacizumab for type 1 retinopathy of prematurity (ROP). A…”
Get full text

Comparison of EX-PRESS Shunt and Trabeculectomy With Mitomycin-C in Congenital and Juvenile Glaucoma by Nash, David L, Crouch, Eric R, Crouch, Earl R

“…PURPOSE:To compare efficacy and safety of EX-PRESS mini glaucoma shunt (Alcon) and trabeculectomy with mitomycin-C (MMC) in the management of pediatric…”
Get full text

Three‐year observation of children 12 to 35 months old with untreated intermittent exotropia by Cotter, Susan A, Mohney, Brian G, Chandler, Danielle L, Holmes, Jonathan M, Wallace, David K, Melia, B Michele, Wu, Rui, Kraker, Raymond T, Superstein, Rosanne, Crouch, Eric R, Paysse, Evelyn A

“…Purpose To describe the clinical course of untreated intermittent exotropia (IXT) in children 12–35 months of age followed for 3 years. Methods We enrolled 97…”
Get full text

A prospective study of treatments for adult-onset divergence insufficiency–type esotropia by Crouch, Eric R., Dean, Trevano W., Kraker, Raymond T., Miller, Aaron M., Kraus, Courtney L., Gunton, Kammi B., Repka, Michael X., Marsh, Justin D., Del Monte, Monte A., Luke, Paula A., Peragallo, Jason H., Lee, Katherine A., Wheeler, Maynard B., Daley, Timothy J., Wallace, David K., Cotter, Susan A., Holmes, Jonathan M.

“…To describe 10-week and 12-month outcomes following treatment for divergence insufficiency–type esotropia in adults. In this prospective observational study,…”
Get full text

Relationships among Clinical Factors and Patient-reported Outcome Measures in Adults with Convergence Insufficiency by Lorenzana, Ingryd J., Leske, David A., Hatt, Sarah R., Dean, Trevano W., Jenewein, Erin C., Dagi, Linda R., Beal, Casey J., Pang, Yi, Retnasothie, Dashaini V., Esposito, Christina A., Erzurum, S. A., Aldrich, Amy E., Crouch, Eric R., Li, Zhuokai, Kraker, Raymond T., Holmes, Jonathan M., Cotter, Susan A.

“…When exploring relationships among clinical measures and patient-reported outcome measures in adults with convergence insufficiency, worse symptoms…”
Get full text

Use of botulinum toxin in strabismus by Crouch, Eric R

“…PURPOSE OF REVIEWThe history, pharmacology, indications, complications, and success rates of botulinum administration are discussed in this review as they…”
Get full text

Primary Treatment of Nasolacrimal Duct Obstruction with Probing in Children Younger than 4 Years by Repka, Michael X, Chandler, Danielle L, Beck, Roy W, Crouch, 3rd, Eric R, Donahue, Sean, Holmes, Jonathan M, Lee, Katherine, Melia, Michele, Quinn, Graham E, Sala, Nick A, Schloff, Susan, Silbert, David I, Wallace, David K

“…Objective To report the outcome of nasolacrimal duct probing as the primary treatment of congenital nasolacrimal duct obstruction (NLDO) in children younger…”
Get full text

Prospective analysis of pediatric pseudophakia: Myopic shift and postoperative outcomes by Crouch, Eric R., Crouch, Earl R., Pressman, Scott H.

“…Purpose: Limited data exist about long-term refractive changes in eyes of children with intraocular lens (IOL) implantation. Information of postoperative…”
Get full text

Office probing for treatment of nasolacrimal duct obstruction in infants by Miller, Aaron M., MD, MBA, Chandler, Danielle L., MSPH, Repka, Michael X., MD, MBA, Hoover, Darren L., MD, Lee, Katherine A., MD, PhD, Melia, Michele, ScM, Rychwalski, Paul J., MD, Silbert, David I., MD

“…Purpose To determine whether demographic or clinical factors are associated with the outcome of office-based nasolacrimal duct probing for the treatment of…”
Get full text

Resolution of nasolacrimal duct obstruction with nonsurgical management in children 6 to <10 months old by Petersen, David B, Chandler, Danielle L, Repka, Michael X, Beck, Roy W, Crouch, Eric R, Lee, Katherine A, Melia, Michele, Morrison, David G, Orge, Faruk H, Ticho, Benjamin H

Get full text

Management of traumatic hyphema: therapeutic options by Crouch, Jr, E R, Crouch, E R

Get more information

Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes by Freedman, Sharon F., Hercinovic, Amra, Wallace, David K., Kraker, Raymond T., Li, Zhuokai, Bhatt, Amit R., Boente, Charline S., Crouch, Eric R., Hubbard, G. Baker, Rogers, David L., VanderVeen, Deborah, Yang, Michael B., Cheung, Nathan L., Cotter, Susan A., Holmes, Jonathan M.

“…Low-dose and very low-dose intravitreal bevacizumab (IVB) have been reported successful in short-term treatment of type 1 retinopathy of prematurity (ROP),…”
Get full text

Rasch-calibrated Intermittent Exotropia Symptom Questionnaire for Children by Holmes, Jonathan M., Leske, David A., Hercinovic, Amra, Hatt, Sarah R., Chandler, Danielle L., Li, Zhuokai, Melia, B. Michele, Chen, Angela M., Erzurum, S. Ayse, Crouch, Eric R., Jenewein, Erin C., Kraker, Raymond T., Cotter, Susan A.

Get full text

Two-year ocular and developmental outcomes of a phase 1 dosing study of bevacizumab for retinopathy of prematurity by Wallace, David K., Hercinovic, Amra, Freedman, Sharon F., Crouch, Eric R., Bhatt, Amit R., Hartnett, M. Elizabeth, Yang, Michael B., Rogers, David L., Hutchinson, Amy K., Good, William V., Repka, Michael X., Kraker, Raymond T., Cotter, Susan A., Holmes, Jonathan M.

Get full text